Genmab — April 2018
-
Apparantly Roche had and other issue with Tecentriq the other day https://endpts.com/roche-halts-enrollment-in-a-phii-combo-study-of-tecentriq-and-cotellic-in-wake-of-several-patient-deaths/
-
Dagens indslag i "sandhedskrigen" https://www.dr.dk/nyheder/udland/rusland-advarer-usas-missiler-kan-oedelaegge-bevis-formodet-giftgasangreb.
-
God morgen
-
God morgen.
-
@OHW11/4 08.43. Jeg kan ikke lige se hvorfor egen salgsorganisation skulle skræmme invesorer væk. For det første begynder de vel ikke at ansætte salgsfolk før de har noget at sælge. Alternativt er de så sikre på det de har at det nu giver menige at ansætte salgsfolk. Sidst men ikke mindst vil jeg mene Genmab bliver mere attraktiv for evt. opkøb hvis de har en fed pipeline som de selv kan sælge fremfor en masse små 20% salgsaftaler med diverse big pharma firmaer.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind